#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11008	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2080	517.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1408	1408	C	606	C	585	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11008	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2080	517.8	0	HET	.	.	.	C451T	.	451	451	C	675	675	C	616	C,T	437,162	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11008	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2080	517.8	0	HET	.	.	.	C207T,G	.	207	207	C	431	431	C	601	C,T,G	453,111,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20866	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3757	547.6	0	.	n	.	0	T695C	SNP	695	695	T	1048	1048	C	629	C,T	599,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20866	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3757	547.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1991	1991	G	683	G	666	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20866	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3757	547.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2324	2324	C	621	C	598	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20866	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3757	547.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2398	2398	A	644	A	628	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20866	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3757	547.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2950	2950	C	642	C	624	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1260	folP	855	855	100.0	folP.l15.c30.ctg.1	1510	82.3	1	SNP	p	R229S	1	.	.	685	687	AGC	912	914	AGC	118;120;122	A;G;C	114;116;112	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4166	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3498	117.3	1	SNP	p	S91F	1	.	.	271	273	TTC	676	678	TTC	131;131;133	T;T;C	128;128;129	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4166	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3498	117.3	1	SNP	p	G95N	0	.	.	283	285	GGC	688	690	GGC	124;124;124	G;G;C	121;122;121	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4166	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3498	117.3	1	SNP	p	D95G	1	.	.	283	285	GGC	688	690	GGC	124;124;124	G;G;C	121;122;121	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1170	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1472	78.1	1	SNP	p	G45D	0	.	.	133	135	GGC	525	527	GGC	137;137;137	G;G;C	133;134;133	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	634	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1012	62.4	0	.	n	.	0	A197.	DEL	197	197	A	551	551	A	131	A	126	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3850	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	127.3	1	SNP	p	D86N	0	.	.	256	258	GAC	599	601	GAC	154;155;156	G,T;A;C	149,1;143;152	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3850	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	127.3	1	SNP	p	S87R	1	.	.	259	261	CGT	602	604	CGT	156;155;155	C;G;T	154;152;151	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3850	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	127.3	1	SNP	p	R87I	0	.	.	259	261	CGT	602	604	CGT	156;155;155	C;G;T	154;152;151	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3850	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	127.3	1	SNP	p	R87W	0	.	.	259	261	CGT	602	604	CGT	156;155;155	C;G;T	154;152;151	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3850	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	127.3	1	SNP	p	S88P	0	.	.	262	264	TCC	605	607	TCC	153;151;148	T;C;C	144;146;145	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2830	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2737	101.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1514	1516	GGC	126;124;123	G;G;C	122;120;119	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1282	1284	GCC	155;157;156	G;C;C,A	151;154;150,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1285	1287	ATG	156;157;156	A;T;G,C	151;151;149,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1297	1299	ACC	157;157;154	A;C;C	151;154;151	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1297	1299	ACC	157;157;154	A;C;C	151;154;151	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1798	1800	ACC	146;147;149	A;C;C	141;141;144	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1852	1854	GCG	146;145;145	G;C;G	142;141;140	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1852	1854	GCG	146;145;145	G;C;G	142;141;140	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1975	1977	GGT	135;133;131	G;G;T	126;124;122	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1984	1986	AGC	119;118;115	A;G;C	113;111;107	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2896	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	119.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2002	2004	CCG	91;91;88	C,G;C,G;G,C	78,2;77,1;73,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4426	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2991	145.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1600	1602	CCG	157;159;160	C;C;G	146;149;151	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1686	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1857	89.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	542	542	C	114	C	106	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2206	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1624	133.5	0	.	p	.	0	G210E	NONSYN	628	630	GGA	1005	1007	GAA	184;181;182	G;A,G;A	174;174,1;177	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2206	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1624	133.5	1	SNP	p	G120K	1	.	.	358	360	AAG	735	737	AAG	182;180;179	A;A;G,A	173;173;164,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2206	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1624	133.5	1	SNP	p	A121N	1	.	.	361	363	AAC	738	740	AAC	181;179;180	A;A;C	173;168;167	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2206	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1624	133.5	1	SNP	p	N121D	0	.	.	361	363	AAC	738	740	AAC	181;179;180	A;A;C	173;168;167	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7726	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4950	153.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	914	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	955	93.5	1	SNP	p	V57M	1	.	.	169	171	ATG	445	447	ATG	171;168;170	A;T;G	162;161;162	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
